Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
Clinical trial NCT05141682 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05141682
- Sponsor
- Jonathan Brammer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-29
- Primary completion
- 2026-02-19
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.